A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double-blind, crossover study is to compare two long-acting
stimulant formulations-once-daily PRC-063 and once-daily lisdexamfetamine (LDX)-through a
15-hour period on driving performance, as measured with a driving simulator, in adult
patients with ADHD.